The receptor UT of urotensin-II is a new target for imaging solid tumor with radiolabeled DOTA-peptide ligands.

Benjamin Poret (1) , Laurence Desrues (1) , Nicolas Perzo (2, 1) , Pierre-Michaël Coly (1) , Jane Eilen Joubert (1) , Pierre-Olivier Guichet (3, 1) , Ma Bonin , Richard Leduc (2) , R Modzelewski (4) , Fabrice Morin (1) , Pierre Vera (4) , Hélène Castel (1) , Pierre Bohn (5) , Pierrick Gandolfo (1)

1 DC2N - Différenciation et communication neuronale et neuroendocrine
2 UdeS - Université de Sherbrooke
3 INM - Institut des Neurosciences de Montpellier
4 Service de médecine nucléaire [Rouen]
5 QuantIF-LITIS - Equipe Quantification en Imagerie Fonctionnelle

Domains: Life Sciences [q-bio]; Life Sciences [q-bio]; Human health and pathology; Life Sciences [q-bio]; Cancer

Benjamin Poret, Laurence Desrues, Nicolas Perzo, Pierre-Michaël Coly, Jane Eilen Joubert, et al.. The receptor UT of urotensin-II is a new target for imaging solid tumor with radiolabeled DOTA-peptide ligands.. 30th Annual Congress of European Association of Nuclear Medicine (EANM), Oct 2017, Vienne, Austria. ⟨hal-02296751⟩